The latest articles from BioStock
» Toleranzia on the way to a new therapy for rare autoimmune disease
» Video presentations from BLSS 2019: sharp examples of both biotech and medical technology
» BLSS 2019 video presentations: Innovation at the center during the second showcase round
» Strong start to BioStock Life Science Summit 2019 – watch the video presentations here
» LIF: Collaboration between business and the public sector is crucial for Sweden's competitiveness
» Well-timed study data ahead of capital round in Aptahem
Read BioStock's latest newsletter for week 43 here
Enorama Pharma is applying for a patent regarding a filling process for nicotine powder with absorption in the oral cavity. Read more.
Klaria Pharma Holding has appointed Lago Capital as a liquidity guarantor for the company's shares. Read more.
Trade in PledPharmas share of Nasdaq Stockholm begins today. Read more.
Navamedic announces that today is the last day for trading in the Nava share including exclusive rights to purchase in Observe Medical. Read more.
The number of votes in Medicover has been changed through conversions of a total of 5 A shares to B shares following a request from shareholders. Read more.
Tolerance vd Charlotte Fribert will present the company at Big Stock Day in Gothenburg on November 4. Read more.
Although Aptahem will give a presentation on Big Stock Day. Read more.
Gedea Biotech reports that all patients in a clinical proof of concept study have completed treatment with pHyph, a vaginal tablet for bacterial vaginosis. Read more.
sectra has signed a five-year agreement with Dutch University Medical Center Groningen (UMCG) regarding a comprehensive solution for medical imaging. Read more.
Peptonics VagiVital to be launched in Hong Kong. Read more.
Stenocares The CEO has commented on the company's first twelve months as a listed company and looks ahead. Read more.
Veloxis improves the forecast for 2019 based on continued good results. Read more.
Stille has appointed a nomination committee for the 2020 Annual General Meeting. Read more.
Christian Hansen Holdings The annual general meeting will be held on November 27. Read more.
A study of virtual implantations in animals that Scandinavian Real Heart is involved in has been published in the journal Artificial Organs. Read more.
IRRAS will hold a conference call and online presentation of its Q3 report on November 14. Read more.
Arcoma has hired Alexis Soh as new business director in Asia. Read more.
Karolinska University Hospital is participating in a global clinical CAR T-cell study for the treatment of aggressive lymphoma. Read more.
A study at Sahlgrenska Academy, University of Gothenburg, shows that bariatric surgery is associated with a clearly reduced risk of skin cancer, which strengthens the link between weight loss and malignant skin cancer. Read more.
Reports/Communiqués:
Boule Diagnostics Moberg Pharma MedCap Diamyd Medical PExA Sobi Hansa Biopharma Annexin Pharmaceuticals NextCell Pharma Lumito European Institute of Science AlphaHelix Molecular Diagnostics Stille Invent Medic Sweden
News received yesterday afternoon:
Biogen and Alkermes has announced that the US Food and Drug Administration FDA has approved VUMERITY (diroximel fumarate) for the treatment of relapsing forms of multiple sclerosis (MS). Read more.
Navamedic has announced that Oslo Stock Exchange has approved the listing of Observe Medical of Oslo Axess. Read more.
MedicPen has supplemented a previous press release regarding the outcome of the company's new share issue. Read more.
RhoVacs chairman of the board Mikael Ørum replaced by Gunnar Gardemyr. Read more.
Genmabs Executive Vice President and Chief Financial Officer, David Eatwell, will retire on February 29, 2020 and will be replaced by the company's Senior Vice President Finance and Corporate Development, Anthony Pagano, March 1, 2020. Read more.
Idogen's vd Anders Karlsson will present the company's operations at Big Stock Day in Gothenburg on November 4. Read more. Lumitos vd Stefan Nilsson will give a presentation at the same time. Read more.
Evaxion Biotech has recruited Glenn S. Vraniak as Chief Financial Officer. Read more.
The industry organization LIF has provided views on the government's research policy ahead of the 2020 Research and Innovation Policy Bill. Read more.
Analyst Group has interviewed Chordate Medicals vd Anders Weilandt. Read more.
Change has signed an agreement with Breast Cancer Foundation New Zealand about providing the service Cambio CDS for symptom monitoring in patients with advanced breast cancer. Read more.
Winners in the lunch trade:
Quiet +23,22% QuickCool +16,55% Camanio Care +16,48% SenzaGen +12,22% Nicoccino Holding +11,61% Spago +7,14%
Losers in the lunch trade:
Annexin Pharmaceuticals -12,92% Medfield -12,50% Sobi -10,66% Prebona -8,92% Hansa Biopharma -6,59% NextCell -6,11%
Index:
OMXS30 -0,55% Healthcare -1,63%
» The search for alternatives to opioids – the Holy Grail of our time?
» Toleranzia's CEO: Several major pharmaceutical companies have already shown interest
» Klaria is developing the cannabis market in a new subsidiary
» Biggest investment in Iconovo's history
» Follicum receives Eurostar grant
» CombiGene pays SEK 1,5 million for new gene therapy asset